Stimulation of Inducible Nitric Oxide by Hepatitis B Virus Transactivator Protein HBx Requires MTA1 Coregulator*
暂无分享,去创建一个
F. Murad | Rakesh Kumar | S. Pakala | E. Martin | Tri M Bui-Nguyen | Suresh B Pakala | Divijendranatha Reddy Sirigiri | Emil Martin | Ferid Murad | Rakesh Kumar | T. Bui-Nguyen | D. Sirigiri | Tri M. Bui-Nguyen | Rakesh Kumar
[1] F. Su,et al. Hepatitis B virus HBx protein activates transcription factor NF-kappaB by acting on multiple cytoplasmic inhibitors of rel-related proteins , 1996, Journal of virology.
[2] J. Moss,et al. Phosphatidylinositol 3-Kinase-dependent Suppression of the Human Inducible Nitric-oxide Synthase Promoter Is Mediated by FKHRL1* , 2006, Journal of Biological Chemistry.
[3] W. Schaffner,et al. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. , 1989, Nucleic acids research.
[4] A. Sarasin,et al. The proapoptotic effect of hepatitis B virus HBx protein correlates with its transactivation activity in stably transfected cell lines , 1999, Oncogene.
[5] Tamer Hifnawy,et al. Associations of pesticides, HCV, HBV, and hepatocellular carcinoma in Egypt. , 2005, International journal of hygiene and environmental health.
[6] Vinod Scaria,et al. Targets for human encoded microRNAs in HIV genes. , 2005, Biochemical and biophysical research communications.
[7] G. Jay,et al. HBx gene of hepatitis B virus induces liver cancer in transgenic mice , 1991, Nature.
[8] W. Hon,et al. Nitric Oxide in Liver Diseases , 2002 .
[9] P. Sarnow,et al. Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA , 2005, Science.
[10] K. Ohshiro,et al. MicroRNA-661, a c/EBPalpha target, inhibits metastatic tumor antigen 1 and regulates its functions. , 2009, Cancer research.
[11] Guan-Tarn Huang,et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. , 2006, JAMA.
[12] B. Slagle,et al. Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene , 1996, Molecular carcinogenesis.
[13] James B. Mitchell,et al. The multifaceted roles of nitric oxide in cancer. , 1998, Carcinogenesis.
[14] R. Lucito,et al. Hepatitis B virus X protein activates transcription factor NF-kappa B without a requirement for protein kinase C , 1992, Journal of virology.
[15] S Amerini,et al. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. , 1994, The Journal of clinical investigation.
[16] E. Tabor. Pathogenesis of hepatitis B virus‐associated hepatocellular carcinoma , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.
[17] M. Hung,et al. NF-κB signaling mediates the induction of MTA1 by hepatitis B virus transactivator protein HBx , 2010, Oncogene.
[18] Sun Park,et al. NF-kappaB activation by hepatitis B virus X (HBx) protein shifts the cellular fate toward survival. , 2002, Cancer letters.
[19] Y. Shin,et al. Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells , 2008, Oncogene.
[20] F. Chisari,et al. Nitric Oxide Inhibits Hepatitis B Virus Replication in the Livers of Transgenic Mice , 2000, The Journal of experimental medicine.
[21] P Rhodes,et al. Roles of nitric oxide in tumor growth. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[22] A. Masumoto,et al. High plasma concentrations of nitrite/nitrate in patients with hepatocellular carcinoma. , 1997, The American journal of gastroenterology.
[23] A. Shiau,et al. Hepatitis B virus X protein sensitizes hepatocellular carcinoma cells to cytolysis induced by E1B-deleted adenovirus through the disruption of p53 function. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[24] C. Cho,et al. Differential effects of selective and non-selective inhibition of nitric oxide synthase on the expression and activity of cyclooxygenase-2 during gastric ulcer healing. , 2006, European journal of pharmacology.
[25] L. Frishman,et al. Repression of Six3 by a corepressor regulates rhodopsin expression , 2007, Proceedings of the National Academy of Sciences.
[26] P Boffetta,et al. A meta‐analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma , 1998, International journal of cancer.
[27] M. Arsura,et al. Nuclear factor-κB and liver carcinogenesis , 2005 .
[28] T. Taniguchi,et al. Possible involvement of nitroglycerin converting step in nitroglycerin tolerance. , 1999, Life sciences.
[29] E. Yu,et al. Metastatic tumor antigen 1 is closely associated with frequent postoperative recurrence and poor survival in patients with hepatocellular carcinoma , 2008, Hepatology.
[30] Sun Mi Park,et al. MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death , 2008, Oncogene.
[31] Anastasios Koulaouzidis,et al. Hepatitis B virus and hepatocarcinogenesis. , 2008, Annals of hepatology.
[32] F. Su,et al. Role of NF-κB and Myc Proteins in Apoptosis Induced by Hepatitis B Virus HBx Protein , 2001, Journal of Virology.
[33] Richard Graham Knowles,et al. Nitric oxide synthase activity in human breast cancer. , 1995, British Journal of Cancer.
[34] E. Masini,et al. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. , 1998, Journal of the National Cancer Institute.
[35] Kamini Singh,et al. MTA family of coregulators in nuclear receptor biology and pathology , 2007, Nuclear receptor signaling.
[36] Vinod Scaria,et al. Host-virus interaction: a new role for microRNAs , 2006, Retrovirology.
[37] V. Scaria,et al. microRNAs in viral oncogenesis , 2007, Retrovirology.
[38] C. Harris,et al. p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells , 1998, Nature Medicine.
[39] E. Lara-Pezzi,et al. Hepatitis B virus X protein transactivates inducible nitric oxide synthase gene promoter through the proximal nuclear factor κB–binding site: Evidence that cytoplasmic location of X protein is essential for gene transactivation , 2001, Hepatology.
[40] E. Petinaki,et al. Nitric oxide and pro-inflammatory cytokines in acute hepatitis B. , 2004, European journal of internal medicine.
[41] Richard J Jackson,et al. How Do MicroRNAs Regulate Gene Expression? , 2007, Science's STKE.
[42] K. Sugimachi,et al. The role of MTA1 gene expression in human hepatocellular carcinoma. , 2003, Oncology reports.
[43] MTA1, a transcriptional activator of breast cancer amplified sequence 3. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[44] V. Kosma,et al. Prognostic significance of iNOS in epithelial ovarian cancer. , 2007, Gynecologic oncology.
[45] M. Manns,et al. Hepatocellular carcinoma in Germany: a retrospective epidemiological study from a low-endemic area. , 2000, Liver.
[46] J. Moss,et al. Mitogen-activated Protein Kinases Mediate Activator Protein-1-dependent Human Inducible Nitric-oxide Synthase Promoter Activation* , 2001, The Journal of Biological Chemistry.
[47] J. Moss,et al. Analysis of the cytokine-stimulated human inducible nitric oxide synthase (iNOS) gene: characterization of differences between human and mouse iNOS promoters. , 1998, Biochemical and biophysical research communications.
[48] Hang Zhang,et al. Effects of hepatitis B virus X protein on the development of liver cancer. , 2006, The Journal of laboratory and clinical medicine.
[49] E. Hildt,et al. Hepatitis B virus-induced oncogenesis. , 2007, World journal of gastroenterology.
[50] S. Ambs,et al. Chronic hepatitis C virus infection in humans: induction of hepatic nitric oxide synthase and proposed mechanisms for carcinogenesis. , 1997, Journal of Surgical Research.
[51] Shou-Dong Lee,et al. Is diabetes a risk factor for hepatocellular carcinoma? , 2004, Gastroenterology.